1294
M. Bulut and Ç. Erk
Vol. 38
17-Phenyl-2,3,5,6,8,9,11,12-octahydro-15H-[1,4,7,10,13]-
pentaoxacyclopentadecino[2,3-g]chromen-15-one (3b).
NMR (CDCl , 400 MHz): δ 3.79 (m, 12H, 6OCH ), 4.00 (m, 4H,
3 2
2OCH ), 4.26 (t, 2H, OCH ), 4.41 (t, 2H, OCH ), 6.89 (d, H,
2
2
2
ArH), 7.22 (d, H, ArH), 7.44 (m, 3H, Ph), 7.71 (d, 2H, Ph), 7.75
Compound 1d (4.60 g, 20 mmol), Na CO (4.25 g, 40 mmol),
2
3
+
+
(s, H, cumH) ms: m/z 456 (M ), 280 (M -C H O ), 196, 140;
8
16 4
DMF (45 mL) and 2a (5.1 g, 20 mmol) treated as outlined above
to afford (3b), 1.23 g (15 %), mp 203 °C (acetonitril); IR (KBr)
For C
H O HRMAS Calcd. 456.178418; Found. 456.178598.
25 28 8
-1
1
2870 (CH ), 1714 (C=O), 1278 (C-H), 1130 (C-O) cm ;
H
14-(4-Methoxyphenyl)-2,3,5,6,8,9-hexahydro-13H-[1,4,7,10]-
tetraoxacyclododecino[2,3-h]chromen-13-one (4d).
2
NMR (CDCl , 400 MHz): δ 3.78 (s, 8H, 4CH ), 3.96 (t, 4H,
3
2
2CH ), 4.20 (m, 4H, 2OCH ), 6.84 (s, H, ArH), 6.95 (s, H, ArH),
2
2
Compound 1c (3.80 g, 20 mmol), Na CO (4.25 g, 40 mmol),
2
3
7.43 (m, 3H, Ph), 7.70 (d, 2H, Ph), 7.72 (s, H, cumH): ms: m/z
DMF (45 mL) and 2d (5.1 g, 20 mmol) reacted as described
above to afford (4d), 2.14 g (27 %), mp 182 °C (THF); IR (KBr)
+
+
412 (M ), 280 (M -C H O ), 225, 199, 140; For C
H O
6
12
3
23 24 7
HRMAS Calcd. 412.152203; Found. 412.149698.
-1
1
2825 (CH ), 1710 (C=O), 1210 (C-H), 1140 (C-O) cm
H
2
;
20-Phenyl-2,3,5,6,8,9,11,12,14,15-nonahydro-18H-[1,4,7,10,-
13,16]hexaoxacyclooctadecino[2,3-g]chromen-18-one (3c).
NMR (CDCl , 400 MHz): δ 3.85 (m, 4H, 2OCH ), 3.87 (s, 3H,
3
2
OCH ), 4.00 (t, 2H, OCH ), 4.26 (t, 2H, OCH ), 4.44 (t, 2H,
3
2
2
OCH ), 6.89 (d, 1H, ArH), 6.99 (d, 2H, ArH), 7.22 (d, 1H, ArH),
2
Compound 1e (2.74 g 10 mmol), K CO (2.76 g, 20 mmol),
2
3
+
7.66 (d, 2H, ArH), 7.68 (s, 1H, cumH): ms: m/z 398 (M ), 310
DMF (30 mL) and 2a (2.55 g, 10 mmol) treated as described
above to afford (3c), 0.49 g (10 %), mp 162 °C (ether); IR (KBr)
+
(M -C H O ), 226, 155; For C
H O HRMAS Calcd.
4
8
2
22 22 7
398.136553; Found. 398.140785.
-1
1
2890 (CH ), 1720 (C=O), 1280 (C-H), 1120 (C-O) cm
H
2
;
NMR (CDCl , 400 MHz): δ 3.68 (s, 4H, 2OCH ), 3.72 (m, 4H,
17-(4-Methoxyphenyl)-2,3,5,6,8,9,11,12-octahydro-15H-
[1,4,7,10,13]pentaoxacyclopentadecino [2,3-h]chromen-15-one
(4e).
3
2
2OCH ), 3.77 (m, 4H, 2OCH ), 3.95 (m, 4H, OCH ), 4.20
2
2
2
(m, 4H, ArH) 6.83 (s, H, ArH), 6.93 (s, H, ArH), 7.40 (m, 3H,
+
Ph), 7.69 (d, 2H, Ph), 7.71 (s, H, cumH): ms: m/z 456 (M ), 280
Compound 1d (4.60 g, 20 mmol), Na CO (4.25 g, 40 mmol),
+
2
3
(M -C H O ), 196, 140; For C
H O HRMAS Calcd.
8
16
4
25 28 8
DMF (45 mL) and 2d (5.1 g, 20 mmol) reacted as described
above to afford (4e), 1.85 g (21 %), mp 134 °C (acetonitrile); IR
456.178418; Found. 412.176691
-1
14-Phenyl-2,3,5,6,8,9-hexahydro-13H-[1,4,7,10]tetraoxacy-
clododecino[2,3-h]chromen-13-one (4a).
(KBr) 2810 (CH ), 1720 (C=O), 1225 (C-H), 1140 (C-O) cm
2
;
1
H NMR (CDCl , 400 MHz): δ 3.76 (m, 4H, 2OCH ), 3.86
3
2
(m, 3H, OCH ), 3.98 (m, 4H, 2OCH ), 4.00 (t, 2H, OCH ), 4.39
3
2
2
Compound 1c (3.80 g, 20 mmol), Na CO (4.25 g, 40 mmol),
2
3
(t, 2H, OCH ), 6.86 (d, 2H, ArH), 6.98 (d, 2H, ArH), 7.19 (d, 1H,
2
DMF (45 mL) and 2c (5.1 g, 20 mmol) treated as described above
to afford (4a), 1.61 g (22 %), mp 177 °C (acetonitril); IR (KBr)
+
ArH), 7.66 (d, 2H, ArH), 7.68 (s, 1H, cumH): ms: m/z 442 (M )
+
310 (M - C H O ), 284, 226, 155; For C
H O HRMAS
-1
1
6
12
3
24 26 8
2825 (CH ), 1710 (C=O), 1290 (C-H), 1118 (C-O) cm
H
2
;
Calcd. 442.162768; Found. 442.163086.
NMR (CDCl , 400 MHz): δ 3.85 (m, 4H, OCH ), 3.88 (t, 2H,
3
2
OCH ), 3.95 (t, 2H, 2OCH ), 4.27 (t, 2H, OCH ), 4.38 (t, 2H,
20-(4-Methoxyphenyl)-2,3,5,6,8,9,11,12,14,15-nonahydro-18H-
[1,4,7,10,13,16]hexaoxacyclooctadecino[2,3-h]chromen-18-one
(4f).
2
2
2
OCH ), 6.87 (d, 1H, ArH), 7.20 (d, 1H, ArH), 7.43 (m, 3H, Ph),
2
+
+
7.68 (d, 2H, Ph), 7.72 (s, H, cumH): ms: m/z 368 (M ), 280 (M -
C H O ), 196, 168, 140; For C HRMAS Calcd.
H
O
6
4
8
2
21 20
Compound 1e (2.74 g 10 mmol), K CO (2.76 g, 20 mmol),
2
3
368.125989; Found. 368.127181.
DMF (30 mL) and 2d (5.1 g, 20 mmol) reacted as described
above to afford (4f), 0.44 g (9 %), mp 112 °C (ether); IR (KBr)
17-Phenyl-2,3,5,6,8,9,11,12-octahydro-15H-[1,4,7,10,13]pen-
taoxacyclopentadecino[2,3-h]chromen-15-one (4b).
-1
1
2825 (CH ), 1715 (C=O), 1215 (C-H), 1150 (C-O) cm
H
2
;
NMR (CDCl , 400 Hz): δ 3.70 (m, 4H, 2OCH ), 3.78 (m, 8H,
3
2
Compound 1d (4.60 g, 20 mmol), Na CO (4.25 g, 40 mmol),
2
3
4OCH ), 3.86 (s, 3H, OCH ), 3.96 (t, 2H, OCH ), 4.02 (t, 2H,
2
3
2
DMF (45 mL) and 2c (5.1 g, 20 mmol) treated as described above
to afford (4b), 1.73 g (21 %), mp 138 °C (acetonitril); IR (KBr)
OCH ), 4.27 (t, 2H, OCH ), 4.38 (t, 2H, OCH ), 6.88 (d, 2H,
2
2
2
ArH), 6.98 (d, 2H, ArH), 7.21 (d, 1H, ArH), 7.66 (d, 2H, ArH),
-1
1
2830 (CH ), 1720 (C=O), 1290 (C-H), 1120 (C-O) cm
H
2
;
+
+
7.69 (s, 1H, cumH): ms: m/z 486 (M ), 310 (M - C H O ),
8
16 4
NMR (CDCl , 400 MHz): δ 3.83 (m, 8H, 4OCH ), 3.87 (t, 2H,
3
2
284, 226, 155; For C
Found 486.187198.
H O HRMAS Calcd. 486.188983;
26 30 9
OCH ), 3.99 (t, 2H, OCH ), 4.25 (t, 2H, OCH ), 4.40 (t, 2H,
2
2
2
OCH ), 6.89 (d, H, ArH), 7.21 (d, H, ArH), 7.42 (m, 3H, Ph),
2
+
7.70 (d, 2H, Ph), 7.75 (s, H, cumH): ms: m/z 412 (M ), 280
(M -C H O ), 225, 196, 140; For C
Acknowledgements.
+
H O HRMAS Calcd.
6
12
3
23 24 7
The support of this work with ITU / DPT-126 project to purchase
the JEOL-FP750 spectrofluorometer was heartily acknowledged.
412.152203; Found. 412.153009.
20-Phenyl-2,3,5,6,8,9,11,12,14,15-nonahydro-18H-
[1,4,7,10,13,16]hexaoxacyclooctadecino[2,3-h]chromen-18-one
(4c).
REFERENCES AND NOTES
Compound 1e (2.74 g 10 mmol), K CO (2.76 g, 20 mmol),
2
3
[1] R. M. Izatt, K. Pawlak, J. S. Bradshaw and R. L. Bruening,
Chem. Rev., 95, 2529 (1995).
[2] J. S. Bradshaw and R. M. Izatt, Accs. Chem. Res., 30, 338
(1997).
DMF (30 mL) and 2c (25.5 g, 10 mmol) treated as described
above to afford (4c), 0.78 g (17 %), mp, 75 °C (THF); IR (KBr)
-1
1
2815 (CH ), 1715 (C=O), 1260 (C-H), 1120 (C-O) cm
H
;
2